VIRX is currently covered by 5 analysts
Viracta Therapeutics's activity chart (see below) currently has 7 price targets and 18 ratings on display. The stock rating distribution of VIRX is 100% BUY.
Analysts' price targets on this stock were met 10% of the time, taking 108.8 days on average.
Highest price target for VIRX is $3, Lowest price target is $1.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 05-Jan-2024. First documented stock forecast 08-Mar-2019.
Currently out of the existing stock ratings of VIRX, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
2 years 10 months 17 days ago
(05-Jan-2024)
0/1 (0%)
$23.98 (217.60%)
Buy
3 years 12 days ago
(10-Nov-2023)
0/2 (0%)
$6.25 (357.14%)
Buy
3 years 12 days ago
(10-Nov-2023)
0/1 (0%)
$7.32 (273.13%)
Buy
$5
$18
3 years 3 months 7 days ago
(15-Aug-2023)
0/2 (0%)
$3.7 (284.62%)
Buy
$36
3 years 7 months 26 days ago
(27-Mar-2023)
1/2 (50%)
$20.3 (129.30%)
544
What is VIRX (Viracta Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on VIRX (Viracta Therapeutics)?
Which analyst has the lowest performance score on VIRX (Viracta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on VIRX (Viracta Therapeutics)?
Which analyst is the currently most bullish on VIRX (Viracta Therapeutics)?
Which analyst is the currently most reserved on VIRX (Viracta Therapeutics)?